[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"app-context":3,"blog-who-owns-west-pharmaceutical-services-top-shareholders-and-recent-insider-trades-ES":222},{"languages":4,"categories":41,"products":125,"competitors":149},[5,9,13,17,21,25,29,33,37],{"name":6,"code":7,"id":8},"English","EN","TGFuZ3VhZ2U6ZW4=",{"name":10,"code":11,"id":12},"Español","ES","TGFuZ3VhZ2U6ZXM=",{"name":14,"code":15,"id":16},"Português","PT","TGFuZ3VhZ2U6cHQ=",{"name":18,"code":19,"id":20},"日本語","JA","TGFuZ3VhZ2U6amE=",{"name":22,"code":23,"id":24},"한국어","KO","TGFuZ3VhZ2U6a28=",{"name":26,"code":27,"id":28},"Deutsch","DE","TGFuZ3VhZ2U6ZGU=",{"name":30,"code":31,"id":32},"Italiano","IT","TGFuZ3VhZ2U6aXQ=",{"name":34,"code":35,"id":36},"Français","FR","TGFuZ3VhZ2U6ZnI=",{"name":38,"code":39,"id":40},"中文 (中国)","ZH","TGFuZ3VhZ2U6emg=",[42,73,104],{"icon":43,"slug":44,"title":45,"description":46,"featuredLinks":47},"mingcute:stock-line","stock-market-basics","Stock Market Basics","\u003Cp>Beginners' guides and practical tips for understanding stock market investing.\u003C\u002Fp>\n",[48,53,58,63,68],{"url":49,"title":50,"description":51,"ogImage":52},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-makes-stocks-go-up-and-down","What Makes Stocks Go Up and Down | TIKR.com","Understanding what makes stock prices go up and down can help investors better navigate investing. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-makes-stocks-go-up-and-down-banner\u002FWhat-makes-stocks-go-up-and-down-banner.jpg?_i=AA",{"url":54,"title":55,"description":56,"ogImage":57},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fdividend-yield-meaning-formula-example","Dividend Yield: Meaning, Formula, Example | Tikr.com Blog | TIKR.com","The dividend yield is a key metric for investors looking to gauge the income potential of their investments. It measures how much a company pays out in","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FDividend-yield\u002FDividend-yield.png?_i=AA",{"url":59,"title":60,"description":61,"ogImage":62},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fmarket-capitalization-definition-formula-and-why-it-matters","Market Capitalization: Definition, Formula, and Why It Matters | TIKR.com","Long-term investors often look at various valuation metrics when deciding whether to invest in a particular company. One helpful metric to evaluate is","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters\u002FMarket-Capitalization-Definition-Formula-and-Why-It-Matters.png?_i=AA",{"url":64,"title":65,"description":66,"ogImage":67},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fearnings-per-share-definition-formula-and-why-eps-matters","Earnings Per Share: Definition, Formula, and Why EPS Matters | TIKR.com","Earnings Per Share (EPS) represents the portion of a company's net earnings allocated to each share. Click to learn more!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEPS-Defiinition-formula-and-why-EPS-matters-1\u002FEPS-Defiinition-formula-and-why-EPS-matters-1.png?_i=AA",{"url":69,"title":70,"description":71,"ogImage":72},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-stock-price-target","What Is a Stock Price Target? | TIKR.com","A price target is a stock's estimated future price. It can help investors quickly find undervalued stocks. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-Stock-Price-Target-2\u002FWhat-is-a-Stock-Price-Target-2.png?_i=AA",{"icon":74,"slug":75,"title":76,"description":77,"featuredLinks":78},"material-symbols:analytics-outline","fundamental-analysis","Fundamental Analysis","\u003Cp>In-depth resources and financial metrics to help you evaluate companies like a pro.\u003C\u002Fp>\n",[79,84,89,94,99],{"url":80,"title":81,"description":82,"ogImage":83},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fshare-repurchase-why-do-companies-buy-back-their-stock","Share Repurchase: Why Do Companies Buy Back Their Stock? | TIKR.com","Share repurchases, or share buybacks, have gained popularity in the last two decades. According to a report from Goldman Sachs, stock buybacks initiated","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e\u002FTIKR-BLOG-COVER-PHOTOS-3_544a7f4e.png?_i=AA",{"url":85,"title":86,"description":87,"ogImage":88},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-invested-capital","What Is a Good Return on Invested Capital? | TIKR.com","Learning about Return on Invested Capital (ROIC) can help investors spot highly profitable stocks that can drive long-term returns. Learn more now!","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-Invested-capital\u002FWhat-is-a-good-return-on-Invested-capital.png?_i=AA",{"url":90,"title":91,"description":92,"ogImage":93},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-return-on-equity-ratio","What is a Good Return on Equity Ratio | Tikr.com Blog | TIKR.com","Return on Equity (ROE) is a financial ratio that reflects a company's profitability in relation to the equity invested by shareholders. It basically","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-return-on-equity-ratio-1\u002FWhat-is-a-good-return-on-equity-ratio-1.jpg?_i=AA",{"url":95,"title":96,"description":97,"ogImage":98},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-a-good-p-e-ratio","What Is a Good P\u002FE Ratio? | TIKR.com","Financial analysts and investors look at various metrics before deciding whether a stock is a buy. One of the metrics is the price-to-earnings ratio (P\u002FE","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-a-good-PE-ratio-1\u002FWhat-is-a-good-PE-ratio-1.jpg?_i=AA",{"url":100,"title":101,"description":102,"ogImage":103},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Ftop-6-metrics-for-investing-in-reits","Top 6 Metrics for Investing in REITs | TIKR.com","Real estate has been one of the greatest asset classes for wealth creation in history, and investing in Real Estate Investment Trusts (REITs) can allow","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FGroup-10\u002FGroup-10.png?_i=AA",{"icon":105,"slug":106,"title":107,"description":108,"featuredLinks":109},"hugeicons:investigation","investing-lingo","Investing Lingo","\u003Cp>A comprehensive glossary of investing terms and jargon so you can speak the language of the markets confidently.\u003C\u002Fp>\n",[110,115,120],{"url":111,"title":112,"description":113,"ogImage":114},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fenterprise-value-definition-and-calculation","Enterprise Value: Definition and Calculation | Tikr.com Blog | TIKR.com","Enterprise value (EV) is a financial metric that offers a comprehensive snapshot of a company's total value. Unlike market capitalization which solely","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEnterprise-Value-Definition-and-Calculation_37576e40\u002FEnterprise-Value-Definition-and-Calculation_37576e40.png?_i=AA",{"url":116,"title":117,"description":118,"ogImage":119},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Febitda-definition-formula-how-to-use-it","EBITDA: Definition, Formula, How to Use It | TIKR.com","EBITDA stands for earnings before interest, taxes, depreciation and amortization. It's a financial metric commonly used to evaluate a company's financial","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FEBITDA-Definition-Formula-How-to-Use-It\u002FEBITDA-Definition-Formula-How-to-Use-It.png?_i=AA",{"url":121,"title":122,"description":123,"ogImage":124},"https:\u002F\u002Fwww.tikr.com\u002Fblog\u002Fwhat-is-the-free-cash-flow-formula-and-why-does-it-matter","What is the Free Cash Flow Formula and Why Does It Matter | TIKR.com","Free cash flow, or FCF, is the cash a company generates after it accounts for outflows required to maintain business operations and support capital","https:\u002F\u002Fwww.tikr.com\u002Fimages\u002FWhat-is-the-free-cash-flow-formula\u002FWhat-is-the-free-cash-flow-formula.png?_i=AA",[126,130,134,137,141,145],{"slug":127,"modified":128,"title":129},"valuation-model-builder","2025-07-03T00:18:53","Value Stocks Quickly and Accurately",{"slug":131,"modified":132,"title":133},"stock-portfolio-tracking","2024-12-02T22:21:28","Monitor Your Portfolio",{"slug":75,"modified":135,"title":136},"2025-01-21T22:10:52","Instantly Analyze Companies with In-Depth Metrics",{"slug":138,"modified":139,"title":140},"stock-screener","2024-12-02T22:13:31","Find the Best Stocks to Buy",{"slug":142,"modified":143,"title":144},"investor-stock-portfolio","2025-01-21T22:02:56","Follow Investment Moves of Top Investors",{"slug":146,"modified":147,"title":148},"analyze-stocks","2025-07-23T16:04:24","Analyze Stocks",[150,154,158,162,166,170,174,178,182,186,190,194,198,202,206,210,214,218],{"slug":151,"title":152,"modified":153},"bloomberg","Bloomberg","2025-01-16T14:23:44",{"slug":155,"title":156,"modified":157},"morningstar","Morningstar","2025-01-16T14:25:16",{"slug":159,"title":160,"modified":161},"sentieo","Sentieo","2025-01-16T17:58:27",{"slug":163,"title":164,"modified":165},"googlefinance","Google Finance","2025-01-17T19:39:37",{"slug":167,"title":168,"modified":169},"tradingview","TradingView","2025-01-16T18:17:01",{"slug":171,"title":172,"modified":173},"factset","Factset","2025-01-16T18:20:16",{"slug":175,"title":176,"modified":177},"finviz","Finviz","2025-01-16T18:23:40",{"slug":179,"title":180,"modified":181},"ycharts","YCharts","2025-01-16T18:32:19",{"slug":183,"title":184,"modified":185},"marketbeat","MarketBeat","2025-03-11T00:27:23",{"slug":187,"title":188,"modified":189},"benzinga","Benzinga","2025-03-11T00:31:00",{"slug":191,"title":192,"modified":193},"gurufocus","Gurufocus","2025-03-11T00:31:12",{"slug":195,"title":196,"modified":197},"fast-graphs","FAST Graphs","2025-03-11T00:31:19",{"slug":199,"title":200,"modified":201},"tipranks","TipRanks","2025-03-11T00:31:26",{"slug":203,"title":204,"modified":205},"seeking-alpha","Seeking Alpha","2025-03-11T00:31:45",{"slug":207,"title":208,"modified":209},"thestreet","TheStreet","2025-03-11T00:31:52",{"slug":211,"title":212,"modified":213},"investing-com","Investing.com","2025-03-11T00:32:00",{"slug":215,"title":216,"modified":217},"zacks","Zacks","2025-03-26T15:40:40",{"slug":219,"title":220,"modified":221},"alphasense","AlphaSense","2025-03-11T00:32:15",{"post":223,"seo":259,"relatedPosts":265,"suggestedPosts":339},{"id":224,"title":225,"date":226,"modified":227,"excerpt":228,"content":229,"wordCount":230,"lang":231,"uri":232,"slug":233,"cloudinaryAssetId":234,"featuredImageOriginalUrl":235,"featuredImageMetadata":236,"author":239,"editor":245,"categories":250,"relatedPosts":256,"seo":257},87749,"¿A quién pertenece West Pharmaceutical Services? Principales accionistas y últimas operaciones con información privilegiada","2026-01-04T20:30:41","2026-01-04T20:30:59","\u003Cp>A continuación se muestra quién tiene las mayores participaciones en West Pharmaceutical Services en la actualidad y qué sugieren las recientes actividades de propiedad y de información privilegiada sobre la confianza en las perspectivas de crecimiento a largo plazo de la empresa.\u003C\u002Fp>\n","\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fstock\u002Fabout?cid=313784&tid=2663879&ref=srk6m3\">\u003Cstrong>West Pharmaceutical Services, Inc. (NYSE: WST)\u003C\u002Fstrong>\u003C\u002Fa> es una empresa del sector sanitario que diseña y fabrica sistemas de contención y suministro de fármacos inyectables utilizados por empresas farmacéuticas y biotecnológicas de todo el mundo. Las acciones cotizaban recientemente en torno a \u003Cstrong> 276 dólares por título\u003C\u002Fstrong>, lo que da a la empresa un valor de mercado de unos \u003Cstrong> 19.900 millones de dólares\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>West Pharmaceutical Services se ha convertido en un socio fundamental para productos biológicos y terapias inyectables complejas. Si observamos quiénes son los propietarios de West Pharmaceutical Services y cómo han operado los iniciados, veremos cómo los grandes inversores parecen estar posicionándose en torno a las acciones en la actualidad.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Descubra el potencial de revalorización de sus acciones favoritas utilizando el nuevo modelo de valoración de TIKR (gratuito) >>>.\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-who-are-west-pharmaceutical-services-top-shareholders\">\u003Cstrong>\u003Cstrong>¿Quiénes son los principales accionistas de West Pharmaceutical Services?\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1471\" height=\"845\" data-public-id=\"images\u002FWST-.2\u002FWST-.2.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1471,h_845,c_scale\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA\" alt=\"West Pharmaceutical Services stock\" class=\"wp-post-87749 wp-image-87750\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1767558263\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA 1471w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_172,c_scale\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_588,c_scale\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_441,c_scale\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_689,c_scale\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_804,c_scale\u002Ff_webp,q_auto\u002Fv1767558263\u002Fimages\u002FWST-.2\u002FWST-.2.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1471px) 100vw, 1471px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Principales accionistas de West Pharmaceutical\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>La base accionarial de West Pharmaceutical Services está liderada por grandes inversores institucionales que tienden a mantenerse a lo largo de los ciclos de mercado, lo que puede ayudar a proporcionar estabilidad a la propiedad a largo plazo. Los gestores activos ajustaron posiciones en ambas direcciones, lo que sugiere una mezcla de convicción y disciplina de valoración.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Grupo Vanguard\u003C\u002Fstrong>: \u003Cstrong>9.671.950 acciones (13,44%)\u003C\u002Fstrong>, \u003Cstrong> valor de 2.670 millones de dólares\u003C\u002Fstrong>. Añadió \u003Cstrong>388.144 acciones\u003C\u002Fstrong> (+4,18%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>BlackRock Institutional Trust Company\u003C\u002Fstrong>: \u003Cstrong>3.794.356 acciones (5,27%)\u003C\u002Fstrong>, \u003Cstrong> por un valor de 1.050 millones de dólares\u003C\u002Fstrong>. Añadidas \u003Cstrong>6.712 acciones\u003C\u002Fstrong> (+0,18%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>State Street Investment Management\u003C\u002Fstrong>: \u003Cstrong>3.207.911 acciones (4,46%)\u003C\u002Fstrong>, \u003Cstrong> valor de 886,7 millones de\u003C\u002Fstrong> dólares. Recortó \u003Cstrong>63.955 acciones\u003C\u002Fstrong> (1,95%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Artisan Partners Limited Partnership\u003C\u002Fstrong>: \u003Cstrong>2.770.920 acciones (3,85%)\u003C\u002Fstrong>, \u003Cstrong> 765,9 millones de dólares de valor\u003C\u002Fstrong>. Añadió \u003Cstrong>503.601 acciones\u003C\u002Fstrong> (+22,21%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Brown Advisory\u003C\u002Fstrong>: \u003Cstrong>2.498.082 acciones (3,47%)\u003C\u002Fstrong>, \u003Cstrong> 690,5 millones de dólares de valor\u003C\u002Fstrong>. Recorta \u003Cstrong>523.201 acciones\u003C\u002Fstrong> (17,32%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Walter Scott & Partners Ltd.\u003C\u002Fstrong>: \u003Cstrong>1.932.390 acciones (2,69%)\u003C\u002Fstrong>, \u003Cstrong> valoradas en 534,1 millones de dólares\u003C\u002Fstrong>. Recorta \u003Cstrong>267.712 acciones\u003C\u002Fstrong> (12,17%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Geode Capital Management\u003C\u002Fstrong>: \u003Cstrong>1.857.124 acciones (2,58%)\u003C\u002Fstrong>, \u003Cstrong> valor de 513,3 millones de dólares\u003C\u002Fstrong>. Ha añadido \u003Cstrong>24.120 acciones\u003C\u002Fstrong> (+1,32%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>VanEck Associates\u003C\u002Fstrong> Corporation: \u003Cstrong>1.424.879 acciones (1,98%)\u003C\u002Fstrong>, \u003Cstrong> 393,8 millones de dólares\u003C\u002Fstrong>. Recorta \u003Cstrong>61.308 acciones\u003C\u002Fstrong> (4,13%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>APG Asset Management\u003C\u002Fstrong>: \u003Cstrong>1.413.698 acciones (1,97%)\u003C\u002Fstrong>, \u003Cstrong> 390,7 millones de dólares\u003C\u002Fstrong>. Recorta \u003Cstrong>244.966 acciones\u003C\u002Fstrong> (14,77%).\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Durable Capital Partners\u003C\u002Fstrong>: \u003Cstrong>1.172.583 acciones (1,63%)\u003C\u002Fstrong>, \u003Cstrong> valor de 324,1 millones de dólares\u003C\u002Fstrong>. Añadió \u003Cstrong>131.935 acciones\u003C\u002Fstrong> (+12,68%).\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>Para los inversores, la combinación de una participación estable de los gestores pasivos y un posicionamiento mixto de los fondos activos sugiere confianza en el negocio a largo plazo de West Pharmaceutical Services, junto con cierta cautela en torno a la valoración a los niveles actuales.\u003C\u002Fp>\n\n\n\n\u003Ch3 class=\"wp-block-heading\" id=\"h-hedge-fund-highlights\">Hechos destacados de los fondos de cobertura\u003C\u002Fh3>\n\n\n\n\u003Cp>Uno de los movimientos más destacados del último trimestre fue el de Citadel Advisors, fundada por Ken Griffin, que aumentó su posición en West Pharmaceutical Services en torno \u003Cstrong>al 465%\u003C\u002Fstrong>. La empresa posee ahora un \u003Cstrong> valor\u003C\u002Fstrong> aproximado de \u003Cstrong> 191 millones de dólares\u003C\u002Fstrong>, lo que parece un aumento significativo, ya que las acciones cotizaban por debajo de los máximos anteriores.\u003C\u002Fp>\n\n\n\n\u003Cp>Otro gran aumento vino de AQR Capital Management, fundada por Cliff Asness, que aumentó su posición en aproximadamente \u003Cstrong>un 420%\u003C\u002Fstrong> a una participación valorada en aproximadamente \u003Cstrong>$ 143M\u003C\u002Fstrong>. Este movimiento sugiere que AQR podría estar valorando más positivamente los fundamentales a largo plazo de West y su perfil de flujo de caja.\u003C\u002Fp>\n\n\n\n\u003Cp>Point72 Asset Management, dirigida por Steven Cohen, también aumentó su exposición, incrementando sus participaciones en casi \u003Cstrong>un 94%\u003C\u002Fstrong>, hasta un \u003Cstrong> valor\u003C\u002Fstrong> aproximado de \u003Cstrong> 173 millones de dólares\u003C\u002Fstrong>. Aunque notable, la posición sigue siendo una parte modesta de la cartera global de la empresa.\u003C\u002Fp>\n\n\n\n\u003Cp>Dimensional Fund Advisors, fundada por David Booth, aumentó sus participaciones en torno \u003Cstrong>al 21%\u003C\u002Fstrong>, con lo que su posición en West Pharmaceutical Services se sitúa justo por debajo de \u003Cstrong> los 100 millones de dólares\u003C\u002Fstrong>, lo que parece más una acumulación constante que un posicionamiento agresivo.\u003C\u002Fp>\n\n\n\n\u003Cp>Para los inversores, la actividad de los hedge funds parece más selectiva que generalizada, lo que apunta a un interés creciente sin que se forme una operación de consenso clara.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Siga a los principales accionistas de más de 50.000 valores mundiales (es gratis) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-west-pharmaceutical-services-recent-insider-trades\">\u003Cstrong>\u003Cstrong>Últimas operaciones con información privilegiada de West Pharmaceutical Services\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg width=\"1473\" height=\"1038\" data-public-id=\"images\u002FWST-.3\u002FWST-.3.webp\" loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1473,h_1038,c_scale\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA\" alt=\"West Pharmaceutical Services stock\" class=\"wp-post-87749 wp-image-87751\" data-format=\"webp\" data-transformations=\"f_webp,q_auto\" data-version=\"1767558269\" data-seo=\"1\" srcset=\"https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA 1473w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_300,h_211,c_scale\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA 300w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1024,h_722,c_scale\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA 1024w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_768,h_541,c_scale\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA 768w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1200,h_846,c_scale\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA 1200w, https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_1400,h_987,c_scale\u002Ff_webp,q_auto\u002Fv1767558269\u002Fimages\u002FWST-.3\u002FWST-.3.webp?_i=AA 1400w\" sizes=\"auto, (max-width: 1473px) 100vw, 1473px\" \u002F>\u003Cfigcaption class=\"wp-element-caption\">Últimas operaciones con información privilegiada de West Pharmaceutical\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\u003Cp>Las transacciones con información privilegiada pueden ofrecer un contexto sobre cómo los ejecutivos y directores pueden estar gestionando su exposición personal. Los archivos recientes de West Pharmaceutical Services muestran sólo pequeñas transacciones que no cambian materialmente la propiedad.\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list\">\n\u003Cli>\u003Cstrong>Robert W. McMahon (Director)\u003C\u002Fstrong>: Vendió acciones en múltiples transacciones el 8\u002F10\u002F25, por un total de entre \u003Cstrong> 200.000 y 3,5 millones de dólares\u003C\u002Fstrong>.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Janet Brutschea Haugen (Directora)\u003C\u002Fstrong>: Vendió aproximadamente \u003Cstrong>$13K\u003C\u002Fstrong> el 9\u002F29\u002F25 y \u003Cstrong>$16K\u003C\u002Fstrong> el 6\u002F29\u002F25.\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cstrong>Shane Alden Campbell (Director)\u003C\u002Fstrong>: Vendió acciones en varias transacciones el 5\u002F11\u002F25 por un total aproximado de \u003Cstrong> 100K$ a 160K$\u003C\u002Fstrong>.\u003C\u002Fli>\n\u003C\u002Ful>\n\n\n\n\u003Cp>Estas operaciones son muy pequeñas en relación con los aproximadamente \u003Cstrong>72 millones de acciones en circulación\u003C\u002Fstrong> de West Pharmaceutical Services y no modifican sustancialmente la titularidad de la información privilegiada. Parece que estas transacciones pueden ser administrativas o estar vinculadas a la gestión de carteras personales, aunque esto no puede confirmarse.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\">\u003Cstrong>\u003Cem>Ver datos recientes de operaciones con información privilegiada de más de 50.000 valores mundiales (Es gratis) >>>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fa>\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-what-the-ownership-amp-insider-trade-data-tell-us\">Qué nos dicen los datos sobre propiedad y operaciones con información privilegiada\u003C\u002Fh2>\n\n\n\n\u003Cp>La propiedad de West Pharmaceutical Services sigue en manos de grandes inversores institucionales, lo que proporciona una base accionarial estable. Los gestores activos muestran un posicionamiento mixto, con algunos añadiendo exposición y otros recortándola, lo que sugiere diferentes puntos de vista sobre la valoración más que un cambio de confianza en el negocio subyacente.\u003C\u002Fp>\n\n\n\n\u003Cp>La actividad de la información privilegiada parece limitada y de pequeña escala, ofreciendo poca señal direccional por sí misma. Para los inversores, los datos sugieren una confianza continuada en el papel de West Pharmaceutical Services en la fabricación de medicamentos inyectables, junto con un enfoque comedido, ya que las acciones cotizan muy por encima de los mínimos anteriores.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\" id=\"h-value-any-stock-in-under-60-seconds-it-s-free\">\u003Cstrong>\u003Cstrong>\u003Cstrong>Valore cualquier acción en menos de 60 segundos (es gratis)\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp>Con la \u003Cstrong>nueva herramienta Modelo de valoración\u003C\u002Fstrong> de TIKR, puede estimar el precio potencial de una acción en menos de un minuto.\u003C\u002Fp>\n\n\n\n\u003Cp>Todo lo que necesita son tres simples datos:\u003C\u002Fp>\n\n\n\n\u003Col class=\"wp-block-list\">\n\u003Cli>\u003Cem>Crecimiento de los ingresos\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Márgenes operativos\u003C\u002Fem>\u003C\u002Fli>\n\n\n\n\u003Cli>\u003Cem>Múltiplo PER de salida\u003C\u002Fem>\u003C\u002Fli>\n\u003C\u002Fol>\n\n\n\n\u003Cp>A partir de ahí, TIKR calcula el precio potencial de la acción y la rentabilidad total en los \u003Cstrong>escenarios\u003C\u002Fstrong> \u003Cstrong>alcista, bajista y básico\u003C\u002Fstrong>, para que pueda ver rápidamente si una acción parece \u003Cstrong>infravalorada o sobrevalorada\u003C\u002Fstrong>.\u003C\u002Fp>\n\n\n\n\u003Cp>Si no está seguro de qué introducir, TIKR rellena automáticamente cada entrada utilizando las estimaciones de consenso de los analistas, ofreciéndole un punto de partida rápido y fiable.\u003C\u002Fp>\n\n\n\n\u003Cp>\u003Cstrong>\u003Cem>\u003Ca href=\"https:\u002F\u002Fapp.tikr.com\u002Fregister?ref=tikrblog\" target=\"_blank\" rel=\"noreferrer noopener\">Vea el valor real de una acción en menos de 60 segundos (gratis con TIKR) >>>\u003C\u002Fa>\u003C\u002Fem>\u003C\u002Fstrong>\u003C\u002Fp>\n",891,"es","\u002Fblog\u002Fwho-owns-west-pharmaceutical-services-top-shareholders-and-recent-insider-trades","who-owns-west-pharmaceutical-services-top-shareholders-and-recent-insider-trades","images\u002FWest-Pharmaceutical-Services-stock_87752ee1d2\u002FWest-Pharmaceutical-Services-stock_87752ee1d2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767558582\u002Fimages\u002FWest-Pharmaceutical-Services-stock_87752ee1d2\u002FWest-Pharmaceutical-Services-stock_87752ee1d2.png?_i=AA",{"altText":237,"imageCredit":238},"Who Owns West Pharmaceutical Services? Top Shareholders and Recent Insider Trades","@Delia Pindaru's Images via Canva",{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":244},"Nikko Henson","nikkotikr","author","",[],{"name":246,"slug":247,"role":248,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":249},"Thomas Richmond","thomastikr","editor",[],[251],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},"Reseñas de Acciones","reviews","\u002Fblog\u002Fcategory\u002Freviews",0,[],{"title":237,"metaDesc":258,"opengraphDescription":258,"twitterTitle":237,"twitterDescription":258},"Here’s who holds the biggest stakes in West Pharmaceutical Services today and what recent ownership and insider activity suggest about confidence in the company’s long term growth outlook.",{"title":237,"description":258,"twitterTitle":237,"twitterDescription":258,"author":240,"articlePublisher":260,"articlePublishedTime":226,"articleModifiedTime":227,"twitterLabel1":261,"twitterData1":262,"ogTitle":237,"ogDescription":258,"ogUrl":232,"ogImage":235,"ogImageWidth":263,"ogImageHeight":264,"ogImageSecureUrl":235,"ogImageAlt":237,"twitterImage":235},"TIKR.com","Tiempo de lectura estimado","7 minutes",1200,630,[266,280,294,309,324],{"id":255,"title":267,"date":268,"excerpt":269,"wordCount":270,"uri":271,"slug":272,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":273,"featuredImageMetadata":274,"author":275,"categories":277,"relatedPosts":279},"¿A quién pertenece Agilent Technologies? Principales accionistas y últimas operaciones con información privilegiada","2026-01-04 12:05:00","A continuación se indica quiénes son los principales accionistas de Agilent Technologies en la actualidad y qué sugieren las recientes actividades de propiedad y de información privilegiada sobre la confianza en la estabilidad de los beneficios de la empresa a largo plazo.",836,"\u002Fblog\u002Fwho-owns-agilent-technologies-top-shareholders-and-recent-insider-trades","who-owns-agilent-technologies-top-shareholders-and-recent-insider-trades","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F01\u002FAgilent-Technologies-via-Canva-600x400.png",{"altText":267},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":276},[],[278],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":281,"date":282,"excerpt":283,"wordCount":284,"uri":285,"slug":286,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":287,"featuredImageMetadata":288,"author":289,"categories":291,"relatedPosts":293},"¿A quién pertenece Teradyne, Inc. Principales accionistas y últimas operaciones con información privilegiada","2026-01-03 19:54:51","A continuación se indica quiénes tienen las mayores participaciones en Teradyne en la actualidad y qué sugieren los recientes movimientos de propiedad y de información privilegiada sobre la confianza en las perspectivas de beneficios de la empresa.",890,"\u002Fblog\u002Fwho-owns-teradyne-inc-top-shareholders-and-recent-insider-trades","who-owns-teradyne-inc-top-shareholders-and-recent-insider-trades","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F01\u002FTeradyne-stock-600x400.png",{"altText":281},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":290},[],[292],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":295,"date":296,"excerpt":297,"wordCount":298,"uri":299,"slug":300,"cloudinaryAssetId":301,"featuredImageOriginalUrl":302,"featuredImageMetadata":303,"author":304,"categories":306,"relatedPosts":308},"¿A quién pertenece Applied Materials? Principales accionistas y últimas operaciones con información privilegiada","2026-01-03 13:35:00","A continuación se muestra quién tiene las mayores participaciones en Applied Materials en la actualidad y qué sugieren los recientes movimientos de propiedad y de información privilegiada sobre la confianza en sus perspectivas de beneficios.",833,"\u002Fblog\u002Fwho-owns-applied-materials-top-shareholders-and-recent-insider-trades","who-owns-applied-materials-top-shareholders-and-recent-insider-trades","images\u002FApplied-Materials-stock_877366ffd1\u002FApplied-Materials-stock_877366ffd1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767442416\u002Fimages\u002FApplied-Materials-stock_877366ffd1\u002FApplied-Materials-stock_877366ffd1.png?_i=AA",{"altText":295},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":305},[],[307],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":310,"date":311,"excerpt":312,"wordCount":313,"uri":314,"slug":315,"cloudinaryAssetId":316,"featuredImageOriginalUrl":317,"featuredImageMetadata":318,"author":319,"categories":321,"relatedPosts":323},"¿A quién pertenece Vertex Pharmaceuticals? Principales accionistas y últimas operaciones con información privilegiada","2026-01-03 13:05:00","A continuación se muestra quién tiene las mayores participaciones en Vertex Pharmaceuticals en la actualidad y qué sugieren las recientes tendencias de propiedad y de información privilegiada sobre la confianza en el poder de los beneficios a largo plazo de la empresa y la durabilidad de la cartera de proyectos.",872,"\u002Fblog\u002Fwho-owns-vertex-pharmaceuticals-top-shareholders-and-recent-insider-trades","who-owns-vertex-pharmaceuticals-top-shareholders-and-recent-insider-trades","images\u002FVertex-Pharmaceuticals-stock_8773116e32\u002FVertex-Pharmaceuticals-stock_8773116e32","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767440573\u002Fimages\u002FVertex-Pharmaceuticals-stock_8773116e32\u002FVertex-Pharmaceuticals-stock_8773116e32.png?_i=AA",{"altText":310},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":320},[],[322],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],{"id":255,"title":325,"date":326,"excerpt":327,"wordCount":328,"uri":329,"slug":330,"cloudinaryAssetId":331,"featuredImageOriginalUrl":332,"featuredImageMetadata":333,"author":334,"categories":336,"relatedPosts":338},"¿A quién pertenece Regeneron Pharmaceuticals? Principales accionistas y últimas operaciones con información privilegiada","2026-01-03 12:35:00","A continuación se indica quiénes tienen las mayores participaciones en Regeneron Pharmaceuticals en la actualidad y qué sugieren las recientes tendencias de propiedad y de información privilegiada sobre la confianza en el poder de los beneficios a largo plazo de la empresa y la solidez de su cartera de proyectos.",994,"\u002Fblog\u002Fwho-owns-regeneron-pharmaceuticals-top-shareholders-and-recent-insider-trades","who-owns-regeneron-pharmaceuticals-top-shareholders-and-recent-insider-trades","images\u002FRegeneron-Pharmaceuticals-stock-1\u002FRegeneron-Pharmaceuticals-stock-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767438954\u002Fimages\u002FRegeneron-Pharmaceuticals-stock-1\u002FRegeneron-Pharmaceuticals-stock-1.png?_i=AA",{"altText":325},{"name":240,"slug":241,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":335},[],[337],{"name":252,"slug":253,"uri":254,"description":243,"postsCount":255},[],[340,359,374,389,404,419,439,454,469,486],{"id":255,"title":341,"date":342,"excerpt":343,"wordCount":344,"uri":345,"slug":346,"cloudinaryAssetId":-1,"featuredImageOriginalUrl":347,"featuredImageMetadata":348,"author":349,"categories":353,"relatedPosts":358},"Por qué las acciones de Broadcom (AVGO) subieron un 50% en 2025","2026-01-02 14:45:00","Broadcom (AVGO), que ha caído un 15% desde sus máximos históricos, es un valor tecnológico de gran capitalización que ha devuelto un 50% a sus accionistas en 2025. ",656,"\u002Fblog\u002Fwhy-broadcom-nasdaq-avgo-stock-rose-50-in-2025","why-broadcom-nasdaq-avgo-stock-rose-50-in-2025","https:\u002F\u002Ftikr1.wpengine.com\u002Fwp-content\u002Fuploads\u002F2026\u002F01\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-8-600x400.png",{"altText":341},{"name":350,"slug":351,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":352},"Aditya Raghunath","adityatikr",[],[354],{"name":355,"slug":356,"uri":357,"description":243,"postsCount":255},"Inversión General","general-investing","\u002Fblog\u002Fcategory\u002Fgeneral-investing",[],{"id":255,"title":360,"date":361,"excerpt":362,"wordCount":363,"uri":364,"slug":365,"cloudinaryAssetId":366,"featuredImageOriginalUrl":367,"featuredImageMetadata":368,"author":369,"categories":371,"relatedPosts":373},"Por qué las acciones de Kratos Defense subieron un 190% en 2025","2026-01-02 14:15:00","Las acciones de Kratos Defense casi triplicaron el patrimonio de los inversores el año pasado, ya que la empresa de seguridad sigue ampliando su foso competitivo. ",1160,"\u002Fblog\u002Fwhy-kratos-defense-nasdaq-ktos-stock-surged-190-in-2025","why-kratos-defense-nasdaq-ktos-stock-surged-190-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767361825\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-7.png?_i=AA",{"altText":360},{"name":350,"slug":351,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":370},[],[372],{"name":355,"slug":356,"uri":357,"description":243,"postsCount":255},[],{"id":255,"title":375,"date":376,"excerpt":377,"wordCount":378,"uri":379,"slug":380,"cloudinaryAssetId":381,"featuredImageOriginalUrl":382,"featuredImageMetadata":383,"author":384,"categories":386,"relatedPosts":388},"Por qué las acciones de Dollar Tree subieron un 64% en 2025","2026-01-02 13:45:00","Las acciones de Dollar Tree subieron un 64% en 2025, aplastando los rendimientos del mercado en general, ya que el minorista de descuento se centró en sus esfuerzos de reconversión. ",966,"\u002Fblog\u002Fwhy-dollar-tree-nasdaq-dltr-stock-rose-64-in-2025","why-dollar-tree-nasdaq-dltr-stock-rose-64-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767360245\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-5_8767165956.png?_i=AA",{"altText":375},{"name":350,"slug":351,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":385},[],[387],{"name":355,"slug":356,"uri":357,"description":243,"postsCount":255},[],{"id":255,"title":390,"date":391,"excerpt":392,"wordCount":393,"uri":394,"slug":395,"cloudinaryAssetId":396,"featuredImageOriginalUrl":397,"featuredImageMetadata":398,"author":399,"categories":401,"relatedPosts":403},"Por qué las acciones de Nebius subieron un 200% en 2025","2026-01-02 12:00:00","Las acciones de Nebius, que han caído un 40% desde sus máximos históricos, se han triplicado con creces en 2025 a medida que ganan terreno en el mercado de la IA, en rápida expansión. ",888,"\u002Fblog\u002Fwhy-nebius-nasdaq-nbis-stock-rose-200-in-2025","why-nebius-nasdaq-nbis-stock-rose-200-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767353835\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-3_87666ecc87.png?_i=AA",{"altText":390},{"name":350,"slug":351,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":400},[],[402],{"name":355,"slug":356,"uri":357,"description":243,"postsCount":255},[],{"id":255,"title":405,"date":406,"excerpt":407,"wordCount":408,"uri":409,"slug":410,"cloudinaryAssetId":411,"featuredImageOriginalUrl":412,"featuredImageMetadata":413,"author":414,"categories":416,"relatedPosts":418},"Por qué las acciones de Asana cayeron un 32% en 2025","2026-01-02 11:15:00","Con una caída de más del 90% desde sus máximos históricos, las acciones de Asana siguieron registrando un rendimiento inferior al de los mercados más amplios en 2025. ",731,"\u002Fblog\u002Fwhy-asana-stock-fell-32-in-2025","why-asana-stock-fell-32-in-2025","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767351571\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15_876606fa98.png?_i=AA",{"altText":405},{"name":350,"slug":351,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":415},[],[417],{"name":355,"slug":356,"uri":357,"description":243,"postsCount":255},[],{"id":255,"title":420,"date":421,"excerpt":422,"wordCount":423,"uri":424,"slug":425,"cloudinaryAssetId":426,"featuredImageOriginalUrl":427,"featuredImageMetadata":428,"author":429,"categories":433,"relatedPosts":438},"CaixaBank acaba de alcanzar máximos históricos. Podrá seguir subiendo en 2026?","2025-12-31 15:15:00","A pesar de un repunte masivo, nuestro modelo muestra que las acciones de CABK podrían rendir alrededor de un 15% hasta 2030 a medida que su negocio de seguros se dispare.",987,"\u002Fblog\u002Fcaixabank-just-hit-all-time-highs-can-the-stock-keep-climbing-in-2026","caixabank-just-hit-all-time-highs-can-the-stock-keep-climbing-in-2026","images\u002F2_873969caee\u002F2_873969caee","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767053079\u002Fimages\u002F2_873969caee\u002F2_873969caee.png?_i=AA",{"altText":420},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":432},"Wiltone Asuncion","wiltonetikr",[],[434],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},"Valoración","valuation","\u002Fblog\u002Fcategory\u002Fvaluation",[],{"id":255,"title":440,"date":441,"excerpt":442,"wordCount":443,"uri":444,"slug":445,"cloudinaryAssetId":446,"featuredImageOriginalUrl":447,"featuredImageMetadata":448,"author":449,"categories":451,"relatedPosts":453},"Las acciones del Banco Bilbao Vizcaya Argentaria (BBVA) han subido un 110% este año, ¿todavía tienen recorrido?","2025-12-31 14:30:00","A pesar de unos márgenes operativos de primera clase, nuestro modelo prevé una rentabilidad anualizada del -1,2% para las acciones de BBVA en los próximos dos años.",1095,"\u002Fblog\u002Fup-110-this-year-does-banco-bilbao-vizcaya-argentaria-bbva-stock-still-have-room-to-run","up-110-this-year-does-banco-bilbao-vizcaya-argentaria-bbva-stock-still-have-room-to-run","images\u002FCopy-of-Random-Featured-Image-1-1\u002FCopy-of-Random-Featured-Image-1-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1766137070\u002Fimages\u002FCopy-of-Random-Featured-Image-1-1\u002FCopy-of-Random-Featured-Image-1-1.png?_i=AA",{"altText":440},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":450},[],[452],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[],{"id":255,"title":455,"date":456,"excerpt":457,"wordCount":458,"uri":459,"slug":460,"cloudinaryAssetId":461,"featuredImageOriginalUrl":462,"featuredImageMetadata":463,"author":464,"categories":466,"relatedPosts":468},"Las acciones del Banco de Sabadell han subido un 300% en los últimos 3 años, ¿podrán continuar su racha en 2026?","2025-12-30 16:15:00","Esta es la razón por la que las acciones de Banco Sabadell han subido un 87% desde sus mínimos de 52 semanas. Las acciones de Banco Sabadell podrían alcanzar su precio objetivo de 3,58 euros en 2029. ",1088,"\u002Fblog\u002Fup-300-over-the-past-3-years-can-banco-de-sabadell-stock-continue-its-run-in-2026","up-300-over-the-past-3-years-can-banco-de-sabadell-stock-continue-its-run-in-2026","images\u002FCopy-of-Random-Featured-Image-2\u002FCopy-of-Random-Featured-Image-2","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1766141023\u002Fimages\u002FCopy-of-Random-Featured-Image-2\u002FCopy-of-Random-Featured-Image-2.png?_i=AA",{"altText":455},{"name":430,"slug":431,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":465},[],[467],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[],{"id":255,"title":470,"date":471,"excerpt":472,"wordCount":473,"uri":474,"slug":475,"cloudinaryAssetId":476,"featuredImageOriginalUrl":477,"featuredImageMetadata":478,"author":479,"categories":483,"relatedPosts":485},"Por qué Netflix podría superar los 131 dólares por acción y alcanzar máximos históricos en 2026","2025-12-30 15:45:00","Netflix podría ofrecer una rentabilidad superior al 30% en 2027, ya que el crecimiento constante de los ingresos, la expansión de los márgenes y unas hipótesis de valoración estables respaldan el alza impulsada por los beneficios.",1212,"\u002Fblog\u002Fheres-why-netflix-could-pass-131-share-and-potentially-reach-all-time-highs-in-2026","heres-why-netflix-could-pass-131-share-and-potentially-reach-all-time-highs-in-2026","images\u002FFEATURED-IMAGE-MAKER-3_86684d6804\u002FFEATURED-IMAGE-MAKER-3_86684d6804","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_360,c_scale\u002Ff_webp,q_auto\u002Fv1765994506\u002Fimages\u002FFEATURED-IMAGE-MAKER-3_86684d6804\u002FFEATURED-IMAGE-MAKER-3_86684d6804.png?_i=AA",{"altText":470},{"name":480,"slug":481,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":482},"Gian Estrada","giantikr",[],[484],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[],{"id":255,"title":487,"date":488,"excerpt":489,"wordCount":490,"uri":491,"slug":492,"cloudinaryAssetId":493,"featuredImageOriginalUrl":494,"featuredImageMetadata":495,"author":496,"categories":498,"relatedPosts":500},"Por qué este valor de mediana capitalización podría subir un 100% en los próximos dos años","2025-12-30 12:30:00","dLocal es un valor de crecimiento de mediana capitalización que cotiza con una valoración atractiva dadas sus estimaciones estelares de ingresos y beneficios. ",1121,"\u002Fblog\u002Fwhy-this-mid-cap-nasdaq-dlo-stock-could-surge-100-over-the-next-two-years","why-this-mid-cap-nasdaq-dlo-stock-could-surge-100-over-the-next-two-years","images\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1","https:\u002F\u002Fres.cloudinary.com\u002Ftikr\u002Fimages\u002Fw_600,h_400,c_scale\u002Ff_webp,q_auto\u002Fv1767093096\u002Fimages\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1\u002FNEW-NOVEMBER-FEATURED-IMAGE-MAKER-15-1.png?_i=AA",{"altText":487},{"name":350,"slug":351,"role":242,"roleTitle":243,"biography":243,"avatar":243,"socialMediaLinks":497},[],[499],{"name":435,"slug":436,"uri":437,"description":243,"postsCount":255},[]]